免费精品视频一区二区三区学生,被3个黑人老外玩的4p,人妻精品无码中文无码一区无,添女人荫蒂全部过

首頁> 美國衛(wèi)生研究院文獻>Infectious Disease Reports >COVID-19 Treatment Guidelines: Do They Really Reflect Best Medical Practices to Manage the Pandemic?
【2h】

COVID-19 Treatment Guidelines: Do They Really Reflect Best Medical Practices to Manage the Pandemic?

機譯:Covid-19治療指南:他們真的反映了最佳的醫(yī)療慣例來管理流行病嗎?

代理獲取
本網(wǎng)站僅為用戶提供外文OA文獻查詢和代理獲取服務(wù),本網(wǎng)站沒有原文。下單后我們將采用程序或人工為您竭誠獲取高質(zhì)量的原文,但由于OA文獻來源多樣且變更頻繁,仍可能出現(xiàn)獲取不到、文獻不完整或與標(biāo)題不符等情況,如果獲取不到我們將提供退款服務(wù)。請知悉。

摘要

SARS-CoV-2 (COVID-19) has been changing the world since December 2019. A comprehensive search into many COVID-19 treatment guidelines was conducted and reported in this article. This is a review paper to probe differences in COVID-19 managing strategies and explore the most common treatment plans among countries. Published guidelines from 23 countries and three references guidelines—until the end of 2020—were included in this article. The majority of COVID-19 treatment options were reported in this review and it includes antiviral drugs, antimalarial drugs, antibiotics, corticosteroids, immunotherapy, anticoagulants, and other pharmacological treatment. The presence of such information from different countries in a single comprehensive review article could help in understanding and speculation of variation in the recommended treatment in each country. This might be related to the cost of medications, the access to the medications, availability of medication that could potentially be useful in managing COVID-19 cases, and the availability/capacity of healthcare facilities. Finally, although there are various treatment groups listed in the published therapeutic guidelines worldwide, unfortunately, there is no evidence for effectiveness of most of these medications in reducing the COVID-19 mortality curve over more than one year of this global pandemic.
機譯:自2019年12月以來,SARS-COV-2(Covid-19)一直在改變世界。在本條中舉行了全面搜索許多Covid-19治療指南。這是一個探討Covid-19管理策略差異,并探討各國中最常見的治療計劃的審查文件。公布了來自23個國家的指南和三個參考指南 - 直到2020年底 - 包含在本條中。在本綜述中報告了大多數(shù)Covid-19治療方案,其中包括抗病毒藥物,抗瘧藥,抗生素,皮質(zhì)類固醇,免疫療法,抗凝血劑和其他藥理學(xué)治療。在一個綜合審查文章中存在來自不同國家的此類信息可以幫助理解和猜測每個國家推薦治療的變化。這可能與藥物的成本有關(guān),可以使用藥物,藥物的可用性可能在管理Covid-19案件方面有用,以及醫(yī)療保健設(shè)施的可用性/容量。最后,雖然全世界公布的治療指南中列出了各種治療組,但不幸的是,沒有證據(jù)表明大多數(shù)這些藥物的有效性減少了在全球大流行的一年以上的一年以上的Covid-19死亡率曲線。

著錄項

相似文獻

  • 外文文獻
  • 中文文獻
  • 專利
代理獲取

客服郵箱:kefu@zhangqiaokeyan.com

京公網(wǎng)安備:11010802029741號 ICP備案號:京ICP備15016152號-6 六維聯(lián)合信息科技 (北京) 有限公司?版權(quán)所有
  • 客服微信

  • 服務(wù)號

主站蜘蛛池模板: 壤塘县| 石渠县| 青龙| 达日县| 天等县| 巫溪县| 吉首市| 镇宁| 观塘区| 盱眙县| 亚东县| 宁化县| 饶河县| 宜城市| 微博| 兴山县| 敖汉旗| 望谟县| 马公市| 张家口市| 铜鼓县| 江孜县| 曲麻莱县| 景宁| 平谷区| 东丰县| 湖口县| 阳东县| 建昌县| 邹城市| 长寿区| 大英县| 同仁县| 凤庆县| 长阳| 阜城县| 赤城县| 防城港市| 岳池县| 外汇| 西藏|